期刊文献+

短肽制剂在终末期患者营养支持中的应用进展

Progress in the Application of Short Peptide Preparations in Nutritional Support for End-Stage Patients
下载PDF
导出
摘要 终末期患者存在感染、高热和低蛋白血症等情况,导致肠道的耐受性下降,从而应用传统的整蛋白型肠内营养制剂容易引起腹胀、腹泻等不良反应,短肽型肠内营养制剂是经过水解处理预消化型营养制剂,能减少胃肠道副反应,使其耐受性增强。本文通过对肠内营养、短肽制剂的优势及功能特点和短肽制剂在终末期患者营养支持的应用和影响进行论述,探讨其临床应用治疗价值,以期为相关临床护理工作提供有价值的参考。In patients with end-stage infection, high fever and hypoalbuminemia, etc., resulting in a decline in the tolerance of the intestinal tract, thus the application of traditional whole protein type enteral nutrition preparations is associated with abdominal distention, diarrhea and other adverse reactions. Short peptide enteral nutrition preparations are predigestive supplements through hydrolysis processing beforehand, can reduce gastrointestinal side effects and enhance its tolerance. In this paper, the advantages and functional characteristics of enteral nutrition, short peptide preparation and the application and influence of short peptide preparation in the nutritional support of end-stage patients were discussed, and the clinical application and therapeutic value of short peptide preparation were discussed, in order to provide valuable reference for relevant clinical nursing work.
出处 《临床医学进展》 2024年第8期194-199,共6页 Advances in Clinical Medicine
  • 相关文献

参考文献11

二级参考文献92

  • 1张建民,冯玲玲.静脉输液药物配伍禁忌调查[J].中国药房,2006,17(20):1572-1574. 被引量:23
  • 2Sultan J,Griffin SM,Di Franco F. Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery[J].British Journal of Surgery,2012,(03):346-355.
  • 3Nakamura M,lwahashi M,Takifuji K. Optimal dose of preoperative enteral immunonutrition for patients with esophageal cancer[J].Surgery Today(Japanese Journal of Surgery ),2009,(10):855-860.
  • 4Takeuchi H,lkeuchi S,Kawaguehi Y. Clinical significance of perioperative immunonutrition for patients with esophageal cancer[J].World Journal of Surgery,2007,(11):2160-2167.
  • 5Barlow R,Price P,Reid TD. Prospective multicentre randomised controlled trial of early enteral nutrition for patients undergoing major upper gastrointestinal surgical resection[J].Clinical Nutrition,2011,(05):560-566.
  • 6Lee JH,Park D J,Kim H. Compari-son of complications after laparoscopy-assisted distal gastrectomy and open distal gastrectomv for gastric cancer using the Clavien-Dindo classification[J].Surgical Endoscopy,2012,(05):1287-1295.
  • 7Ankera SD,John M,Pedersen PU. ESPEN guidelines on enteral nutrition:cardiology and pulmonology[J].Clinical Nutrition,2006,(02):311-318.doi:10.1016/j.clnu.2006.01.017.
  • 8Lidder P,Flanagan D,Fleming S. Combining enteral with parenteral nutrition to improve postoperative glucose control[J].British Journal of Nutrition,2010,(11):1635-1641.
  • 9Heyland DK,Dhaliwal R,Drover JW. Canadian clinical praetiee guidelines for nutrition support in mechanically ventilated,critically ill adult patients[J].Journal of Parenteral and Enteral Nutrition,2003,(05):355-373.
  • 10Tomaszek SC,Cassivi SD,Allen MS. An alternative postoperative pathway reduces length of hospitalisation following oesophageetomy[J].European Journal of Cardio-Thoracic Surgery,2010,(04):807-813.

共引文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部